DE2514537A1 - Verfahren zur stabilisierung von interferon - Google Patents
Verfahren zur stabilisierung von interferonInfo
- Publication number
- DE2514537A1 DE2514537A1 DE19752514537 DE2514537A DE2514537A1 DE 2514537 A1 DE2514537 A1 DE 2514537A1 DE 19752514537 DE19752514537 DE 19752514537 DE 2514537 A DE2514537 A DE 2514537A DE 2514537 A1 DE2514537 A1 DE 2514537A1
- Authority
- DE
- Germany
- Prior art keywords
- interferon
- solution
- agent
- urea
- active agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7404589A NL7404589A (nl) | 1974-04-03 | 1974-04-03 | Werkwijze voor het stabiliseren van interferon. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2514537A1 true DE2514537A1 (de) | 1975-10-09 |
Family
ID=19821109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752514537 Withdrawn DE2514537A1 (de) | 1974-04-03 | 1975-04-03 | Verfahren zur stabilisierung von interferon |
Country Status (11)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0138087A1 (en) * | 1983-09-20 | 1985-04-24 | F. Hoffmann-La Roche Ag | Immune interferon and method for its purification |
| EP0140127A1 (en) * | 1983-09-20 | 1985-05-08 | F. Hoffmann-La Roche Ag | Process for the preparation of immune interferon |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4100150A (en) * | 1975-11-04 | 1978-07-11 | G. D. Searle & Co. | Stabilization of interferon against mechanical stress using thioctic acid |
| FR2351665A1 (fr) * | 1976-05-21 | 1977-12-16 | Elf Aquitaine | Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament |
| IN150740B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
| US4503035B1 (en) * | 1978-11-24 | 1996-03-19 | Hoffmann La Roche | Protein purification process and product |
| US6410697B1 (en) | 1979-04-20 | 2002-06-25 | Schering Corporation | Process for purifying human leukocyte interferon |
| US4289689A (en) * | 1980-03-14 | 1981-09-15 | Hoffmann-La Roche Inc. | Preparation of homogeneous human fibroblast interferon |
| US4252791A (en) * | 1979-10-19 | 1981-02-24 | The Medical College Of Wisconsin, Inc. | Interferon stabilization |
| WO1986001723A1 (fr) * | 1984-09-21 | 1986-03-27 | Vsesojuzny Nauchno-Issledovatelsky Institut Osobo | Procede de rectification d'interferon leukocytique humain |
| IE57069B1 (en) | 1980-04-03 | 1992-04-22 | Biogen Inc | Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon |
| EP0305551A3 (en) * | 1981-10-13 | 1990-01-10 | Exovir, Inc. | Pharmaceutical compositions for topical application |
| US5582824A (en) * | 1981-10-19 | 1996-12-10 | Genentech, Inc. | Recombinant DES-CYS-TYR-CYS human immune interferon |
| JPS58167520A (ja) * | 1982-03-27 | 1983-10-03 | Sunstar Inc | インタ−フエロン安定配合製剤 |
| EP0080879B1 (en) * | 1981-11-28 | 1986-10-01 | Sunstar Kabushiki Kaisha | Pharmaceutical composition containing interferon in stable state |
| US5702699A (en) * | 1982-09-23 | 1997-12-30 | Cetus Corporation | Process for the recovery of lipophilic proteins |
| US4681930A (en) * | 1983-09-20 | 1987-07-21 | Hoffmann-La Roche Inc. | Immune interferon and a method for its extraction and purification |
| JPS6079000A (ja) * | 1983-10-04 | 1985-05-04 | Takeda Chem Ind Ltd | ヒトγ型インタ−フエロン単量体の製造法 |
| MX9203641A (es) * | 1983-12-16 | 1992-07-01 | Genentech Inc | Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion. |
| US4855238A (en) | 1983-12-16 | 1989-08-08 | Genentech, Inc. | Recombinant gamma interferons having enhanced stability and methods therefor |
| IL74093A0 (en) * | 1984-01-23 | 1985-04-30 | Takeda Chemical Industries Ltd | Stable composition of gamma-interferon |
| JPS61277633A (ja) * | 1985-05-31 | 1986-12-08 | Toray Ind Inc | インタ−フエロン組成物 |
| JP2577742B2 (ja) * | 1986-07-18 | 1997-02-05 | 中外製薬株式会社 | 安定な顆粒球コロニ−刺激因子含有製剤 |
| US4950470A (en) * | 1986-10-06 | 1990-08-21 | Board Of Regents, The University Of Texas System | Methods and compositions employing interferon-gamma |
| US5165921A (en) * | 1989-01-23 | 1992-11-24 | National Geno Sciences, Inc. | Method for treating condyloma acuminatum with interferon |
| US5236707A (en) * | 1991-11-08 | 1993-08-17 | Dallas Biotherapeutics, Inc. | Stabilization of human interferon |
| US6399296B1 (en) * | 1994-07-20 | 2002-06-04 | The General Hospital Corporation | Interaction trap systems for detecting protein interactions |
| GB0002660D0 (en) * | 2000-02-04 | 2000-03-29 | Biomade B V | Method of stabilizing a hydrophobin-containing solution and a method of coatinga surface with a hydrophobin |
| AR034749A1 (es) * | 2001-07-09 | 2004-03-17 | Schering Ag | Formulaciones de interferon beta humano |
-
1974
- 1974-04-03 NL NL7404589A patent/NL7404589A/xx not_active Application Discontinuation
-
1975
- 1975-03-20 BE BE1006541A patent/BE826889A/xx unknown
- 1975-03-26 AU AU79512/75A patent/AU7951275A/en not_active Expired
- 1975-03-27 FI FI750951A patent/FI750951A7/fi not_active Application Discontinuation
- 1975-04-02 DK DK139775A patent/DK139775A/da unknown
- 1975-04-02 FR FR7510302A patent/FR2266740B3/fr not_active Expired
- 1975-04-02 SE SE7503769A patent/SE7503769L/xx unknown
- 1975-04-02 NO NO751118A patent/NO751118L/no unknown
- 1975-04-03 JP JP50040754A patent/JPS5132725A/ja active Pending
- 1975-04-03 DE DE19752514537 patent/DE2514537A1/de not_active Withdrawn
- 1975-04-03 US US05/564,723 patent/US3981991A/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0138087A1 (en) * | 1983-09-20 | 1985-04-24 | F. Hoffmann-La Roche Ag | Immune interferon and method for its purification |
| EP0140127A1 (en) * | 1983-09-20 | 1985-05-08 | F. Hoffmann-La Roche Ag | Process for the preparation of immune interferon |
Also Published As
| Publication number | Publication date |
|---|---|
| DK139775A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-10-04 |
| BE826889A (nl) | 1975-09-22 |
| AU7951275A (en) | 1976-09-30 |
| NO751118L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-10-06 |
| US3981991A (en) | 1976-09-21 |
| FR2266740A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-10-31 |
| SE7503769L (sv) | 1975-10-06 |
| NL7404589A (nl) | 1975-10-07 |
| JPS5132725A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-03-19 |
| FI750951A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-10-04 |
| FR2266740B3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2514537A1 (de) | Verfahren zur stabilisierung von interferon | |
| DE3932469C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE69917285T2 (de) | Stabilisierte zusammensetzungen mit antibakterieller wirksamkeit | |
| DE2514536A1 (de) | Verfahren zur reaktivierung von interferon | |
| DE2324717C3 (de) | Verfahren zur Herstellung eines stabilen AHF-Konzentrates (Faktor VIII) | |
| DE1930957B2 (de) | Wasserlösliches Silbersalz ent haltendes Gel zur Behandlung von Ver brennungen | |
| DE3238820A1 (de) | Reinigungsmittel fuer kontaktlinsen | |
| DE3519073A1 (de) | Kuenstliches knochenerzeugendes biomaterial und verfahren zu seiner herstellung | |
| DE2927841A1 (de) | Verfahren zur herstellung einer biologischen zusammensetzung zur verwendung als blutserum-bezugszusammensetzung fuer diagnostische analysezwecke | |
| DE2500076A1 (de) | Verfahren zur erhoehung der intravenoesvertraeglichkeit von aus blut oder blutprodukten ausgefaellten gammaglobulinen | |
| DE2248475C3 (de) | Verfahren zur Gewinnung von hepatitissicheren, lagerungsstabilen und infundierbaren Hämoglobinlösungen | |
| DE2717002A1 (de) | Dauerwell-mischung | |
| DE2827297A1 (de) | Verfahren zum sterilisieren eines aus blut oder einer blutfraktion gewonnenen pulvers | |
| EP0114351A2 (de) | Verfahren zur Herstellung eines Kollagen-Vlieses | |
| DE3421789C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2331550A1 (de) | Festes proteinprodukt enthaltend fibrinogen | |
| DE3686702T2 (de) | Biologisch aktive topische kollagentraegermatrix: kosmetische und pharmazeutische verwendung und verfahren zu deren herstellung. | |
| DE1188764B (de) | Desinfektionsmittel | |
| DE69428020T2 (de) | Topische antibakterielle Zusammensetzung | |
| EP0537429B1 (de) | Modifizierte Huminate, Verfahren zu ihrer Herstellung und Verwendung | |
| DE1227615B (de) | Verfahren zur Herstellung stabiler Impfstoffpraeparate | |
| DE2549768A1 (de) | Verfahren zum stabilisieren von interferon gegen mechanische beanspruchung | |
| DE2420415A1 (de) | Eine mitogenische blutfraktion und verfahren zur herstellung derselben | |
| DE1155134B (de) | Verfahren zur Herstellung von Blutplasmaersatzmitteln aus Kollagenabbauprodukten | |
| DE1086012B (de) | Verfahren zur Herstellung von protrahiert wirkenden Vitamin-B-Praeparaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8141 | Disposal/no request for examination | ||
| 8180 | Miscellaneous part 1 |
Free format text: KURZFRISTIGE WIEDEREINSETZUNG WEGEN FALSCH VEROEFFENTLICHTEM ERLEDIGUNGSGRUND. DIE VEROEFFFENTLICHUNG DES ZUTREFFENDEN ERLEDIGUNGSGRUNDES ERFOLGT IM NAECHSTEN PATENTBLATT. |
|
| 8139 | Disposal/non-payment of the annual fee |